Literature DB >> 33350324

Congenital Solitary Kidney from Birth to Adulthood.

Pierluigi Marzuillo1, Stefano Guarino1, Anna Di Sessa1, Pier Francesco Rambaldi2, Alfonso Reginelli3, Giovanna Vacca3, Salvatore Cappabianca3, Daniela Capalbo1, Tiziana Esposito1, Carla De Luca Picione1, Maria Rosaria Arienzo1, Grazia Cirillo1, Angela La Manna1, Emanuele Miraglia Del Giudice1, Cesare Polito1.   

Abstract

PURPOSE: To evaluate the course of prenatally diagnosed and early-enrolled congenital solitary functioning kidney patients followed until adulthood and to identify risk factors for kidney injury.
MATERIALS AND METHODS: Among all congenital solitary functioning kidney patients followed (1993-2018), we recalled 56 patients with prenatal diagnosis and congenital solitary functioning kidney confirmation at 1-3 months of life reaching at least 18 years of age. Serum uric acid, heavy smoking (≥25 cigarettes/day) and overweight/obesity were clustered as modifiable risk factors. Kidney injury was defined by estimated glomerular filtration rate <90 ml/minute/1.73 m2 and/or 24-hour ambulatory blood pressure monitoring confirmed hypertension and/or proteinuria. Modifiable risk factors and congenital anomalies of the kidney and urinary tract (CAKUT) of congenital solitary functioning kidney were evaluated as risk factors for kidney injury.
RESULTS: The mean followup period was 21.1 years (range 18-33 years). Mild kidney injury was found in 15 out of 56 patients (26.8%). The mean age at proteinuria, reduced estimated glomerular filtration rate and hypertension onset was 19.7 years (1.2 SDS), 20.7 years (2.7 SDS), and 22 years (5.6 SDS), respectively. Patients with CAKUT of congenital solitary functioning kidney and with both CAKUT of congenital solitary functioning kidney and modifiable risk factors presented survival free from kidney injury of 0% at 22.2 and 24.2 years of age, respectively. Patients with modifiable risk factors presented 42.4% of survival at 30 years. Patients without CAKUT of congenital solitary functioning kidney nor modifiable risk factors presented 100% of survival at 30 years of age (p=0.002). The presence of CAKUT of congenital solitary functioning kidney was the only significant risk factor (HR 4.9; 95% CI 1.8-14.2; p=0.003).
CONCLUSIONS: The outcomes of congenital solitary functioning kidney in early adulthood appear better than previously reported. Prompt diagnosis of congenital solitary functioning kidney, healthy lifestyle promotion and monitoring of serum uric acid may improve the prognosis of congenital solitary functioning kidney patients.

Entities:  

Keywords:  solitary kidney; renal insufficiency, chronic; obesity; smoking; uric acid

Year:  2020        PMID: 33350324     DOI: 10.1097/JU.0000000000001524

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  Brief Early Life Angiotensin-Converting Enzyme Inhibition Offers Renoprotection in Sheep with a Solitary Functioning Kidney at 8 Months of Age.

Authors:  Zoe McArdle; Reetu R Singh; Helle Bielefeldt-Ohmann; Karen M Moritz; Michiel F Schreuder; Kate M Denton
Journal:  J Am Soc Nephrol       Date:  2022-03-29       Impact factor: 14.978

2.  Risk stratification for children with a solitary functioning kidney.

Authors:  Sander Groen In't Woud; Loes F M van der Zanden; Michiel F Schreuder
Journal:  Pediatr Nephrol       Date:  2021-11       Impact factor: 3.714

3.  Early Renal Ultrasound in Patients with Congenital Solitary Kidney Can Guide Follow-Up Strategy Reducing Costs While Keeping Long-Term Prognostic Information.

Authors:  Stefano Guarino; Anna Di Sessa; Simona Riccio; Daniela Capalbo; Alfonso Reginelli; Salvatore Cappabianca; Pier Francesco Rambaldi; Emanuele Miraglia Del Giudice; Cesare Polito; Pierluigi Marzuillo
Journal:  J Clin Med       Date:  2022-02-17       Impact factor: 4.241

Review 4.  New Insights from Metabolomics in Pediatric Renal Diseases.

Authors:  Simona Riccio; Maria Sole Valentino; Antonio Paride Passaro; Marica Izzo; Stefano Guarino; Emanuele Miraglia Del Giudice; Pierluigi Marzuillo; Anna Di Sessa
Journal:  Children (Basel)       Date:  2022-01-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.